Exane Derivatives’s Citigroup C Stock Holding History
Bought
Maintained
Sold
Other funds holding C
Exane Derivatives's C Position: Q2 2022 in Review
Exane Derivatives increased its Citigroup (C) stake by 26% in Q2 2022, buying an estimated $515K and bringing the position to 50,565 shares worth $2.32M. The position accounts for 1.34% of the portfolio, ranked #12.
Exane Derivatives first reported a position in C in Q4 2014 and has held it in 28 quarters since. The position peaked at $5.94M in Q4 2014. 1,659 funds tracked by Wall St. Rank hold C as of Q2 2022.
- Exane Derivatives held 50,565 shares of Citigroup worth $2.32M as of Q2 2022.
- Exane Derivatives bought 10,292 Citigroup shares in Q2 2022, an estimated $515K.
- Citigroup made up 1.34% of Exane Derivatives's portfolio in Q2 2022, its #12 holding.
- Exane Derivatives first reported a position in Citigroup in Q4 2014 and has held it in 28 quarters since.
- Exane Derivatives's Citigroup position peaked at $5.94M in Q4 2014.
- 1,659 funds tracked by Wall St. Rank held Citigroup as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.